AbbVie Inc. News Headlines

ABBV 
$55.2
*  
0.24
0.44%
Get ABBV Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ABBV After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU - Analyst Blog
8/5/2014 5:50:00 PM - Zacks.com

Is AbbVie A Long-Term Buy?
8/5/2014 3:05:00 PM - Seeking Alpha

3 Businesses That Stand To Lose With Budding Marijuana Acceptance
8/5/2014 1:41:00 PM - Seeking Alpha

Update: Lemelson Capital Further Increases Short Stake In Ligand Pharmaceuticals As EPS Plunges 76% In Q2 2014
8/4/2014 3:10:00 PM - Seeking Alpha

AbbVie Shareholders Prevail
8/1/2014 10:05:00 AM - Seeking Alpha

The Stocks Already in Correction Mode
8/1/2014 9:30:00 AM - Fox Business

The Stocks Already in Correction Mode
8/1/2014 8:15:00 AM - Fox Business

3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP
7/31/2014 11:44:13 AM - Zacks.com

A Macroeconomic Roadmap For The Remainder Of 2014
7/31/2014 10:36:00 AM - Seeking Alpha

Why It Can Be Self-Destructive To Compare Yourself To The S&P 500
7/29/2014 8:38:00 PM - Seeking Alpha

After Hours Most Active for Jul 29, 2014 : TWTR, BAC, T, PFE, ABBV, BBRY, S, QQQ, MSFT, FB, MU, SIRI
7/29/2014 4:44:59 PM - NASDAQ.com News

Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures - Analyst Blog
7/29/2014 10:38:00 AM - Zacks.com

Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View - Analyst Blog
7/29/2014 8:13:00 AM - Zacks.com

Novartis Division Gets European Approval for Simbrinza - Analyst Blog
7/28/2014 6:30:00 PM - Zacks.com

Reports: Danone In Talks To Sell Medical Nutrition Unit To Hospira For $5 Bln
7/27/2014 11:34:00 PM - RTT News

Market Ignores AbbVie's Impressive Sales Due To Reliance On Humira
7/26/2014 3:05:00 AM - Seeking Alpha

AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus - Analyst Blog
7/25/2014 11:52:00 AM - Zacks.com

U.S. Hot Stocks: Hot Stocks to Watch
7/25/2014 9:28:00 AM - Dow Jones Business News

AbbVie Q2 Profit Rises, Results Beat View; Affirms 2014 Outlook
7/25/2014 9:12:00 AM - RTT News

Sector Update: Health Care
7/25/2014 9:04:10 AM - MT Newswires

Sector Update: Health-Care Shares Flat to Higher Pre-Market
7/25/2014 9:04:00 AM - MT Newswires

AbbVie Q2 Results Beat Estimates - Quick Facts
7/25/2014 8:01:00 AM - RTT News

Shire, ArmaGen Ink Licensing Agreeement for AGT-182 - Analyst Blog
7/24/2014 6:00:00 PM - Zacks.com

Merck Looks Overpriced Compared To This Sector Peer
7/24/2014 5:42:00 PM - Seeking Alpha

Pre-Market Earnings Report for July 25, 2014 : ABBV, LYB, COV, AON, AEP, TYC, MCO, XRX, DTE, SWK, FMX, LEA
7/24/2014 4:00:03 PM - NASDAQ.com News